Retraction: “Concurrent Inhibition of NF-κB, Cyclooxygenase-2, and Epidermal Growth Factor Receptor Leads to Greater Anti-Tumor Activity in Pancreatic Cancer” by Ali Et Al.

Journal of Cellular Biochemistry - United States
doi 10.1002/jcb.25586
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Wiley

Related search

Retraction: Antitumor Activity of Epidermal Growth Factor Receptor—Related Protein Is Mediated by Inactivation of ErbB Receptors and Nuclear Factor-κB in Pancreatic Cancer

Cancer Research
Cancer ResearchOncology
2018English

Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 as a Novel Approach to Enhance Radiotherapy

Journal of Cell Science & Therapy
2011English

Retraction: “Inactivation of Ink4a/Arf Leads to Deregulated Expression of miRNAs in K-Ras Transgenic Mouse Model of Pancreatic Cancer” by Ali Et Al.

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2016English

Cyclooxygenase-2, Epidermal Growth Factor Receptor, and Aromatase Signaling in Inflammation and Mesothelioma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Treatment of Pancreatic Cancer With Epidermal Growth Factor Receptor-Targeted Therapy

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Anti-Oncogenic Activity of Signalling-Defective Epidermal Growth Factor Receptor Mutants.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1992English

Continuous Inhibition of Epidermal Growth Factor Receptor Phosphorylation by Erlotinib Enhances Antitumor Activity of Chemotherapy in Erlotinib-Resistant Tumor Xenografts

Oncology Reports
MedicineCancer ResearchOncology
2011English

Retraction for Lammerts Van Bueren Et Al., the Antibody Zalutumumab Inhibits Epidermal Growth Factor Receptor Signaling by Limiting Intra- And Intermolecular Flexibility

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Epidermal Growth Factor Receptor Inhibition Strategies in Oncology

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy